Search results for "Ophthalmic solutions"

showing 10 items of 40 documents

In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells

2019

Abstract Purpose Benzalkonium chloride is the most widely used preservative in ophthalmic topical solutions. The aim of this study was to investigate the influence of BAC as a single substance or as a component of several commercially available ophthalmic solutions on meibomian gland epithelial cells in vitro. Materials and methods An immortalized human meibomian gland epithelial cell line (HMGEC) was used and cells were cultured in the absence or presence of fetal bovine serum to assess cell morphology, cell proliferation, cell viability (MTS assay) and impedance sensing (ECIS) after stimulation with BAC. Further, the viability of HMGECs stimulated with BAC-containing and BAC-free bimatopr…

0301 basic medicineCell SurvivalMeibomian glandReal-Time Polymerase Chain ReactionCell morphologyCell Line03 medical and health sciencesBenzalkonium chloridemedicineHumansViability assayProtein PrecursorsInvolucrinCell ProliferationCell growthChemistryPreservatives PharmaceuticalMeibomian GlandsDrug SynergismEpithelial CellsGeneral MedicineMolecular biology030104 developmental biologymedicine.anatomical_structureToxicityProstaglandinsKeratins030101 anatomy & morphologyOphthalmic SolutionsAnatomyBenzalkonium CompoundsFetal bovine serumDevelopmental Biologymedicine.drugAnnals of Anatomy - Anatomischer Anzeiger
researchProduct

Reply to Comment on: 'Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine'

2017

Reply to Comment on: ‘Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine’

0301 basic medicineLaser Microscopymedicine.medical_specialtygenetic structuresConfocalAdministration TopicaleducationDry Eye SyndromesOphthalmic SolutionCornea03 medical and health sciencesImmunosuppressive Agent0302 clinical medicineOphthalmologyCorneaMicroscopyCorrespondenceMedicineHumansIn patientOphthalmology; Sensory Systems; Dry Eye; Corneal confocal scanning laser microscopyCorneal confocal scanning laser microscopyMicroscopy Confocalbusiness.industryDry Eyeeye diseasesSensory SystemsOphthalmology030104 developmental biologyOphthalmic solutionsmedicine.anatomical_structure030221 ophthalmology & optometryCyclosporineDry Eye Syndromessense organsOphthalmic SolutionsbusinessImmunosuppressive AgentsHuman
researchProduct

The human meibomian gland epithelial cell line as a model to study meibomian gland dysfunction

2016

The meibomian gland dysfunction (MGD) is the leading cause of dry eye disease (DED) throughout the world. The investigation of MGD lacks suitable in vivo and in vitro models. In 2010 a human meibomian gland epithelial cell line (HMGEC) was established, so far the only available meibomian gland cell line. The characterization of HMGEC is of major importance to clarify its suitability for studying the meibomian gland (patho)physiology in vitro. The current culture protocol and new concepts of HMGEC culture will be compared. Hormones are believed to be a key factor in meibomian gland dysfunction thus HMGEC responsiveness to hormone stimulation is crucial to elucidate the hormonal influence on …

0301 basic medicinePathologymedicine.medical_specialtyMeibomian glandBiologyModels BiologicalCell Line03 medical and health sciencesCellular and Molecular NeuroscienceHormone stimulation0302 clinical medicinestomatognathic systemRisk FactorsmedicineHumansGonadal Steroid HormonesCells Culturedintegumentary systemMeibomian gland dysfunctionMeibomian GlandsEpithelial CellsSensory SystemsEpitheliumAnti-Bacterial Agentsbody regionsOphthalmology030104 developmental biologymedicine.anatomical_structure030221 ophthalmology & optometryDry Eye Syndromessense organsOphthalmic SolutionsHormoneExperimental Eye Research
researchProduct

Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test.

2015

Tacrolimus ocular preparations are commonly employed in autoimmune or inflammatory ocular disorders. However, currently there are not yet approved ocular formulations. Tacrolimus ocular side effects have been reported in clinical use, so the evaluation of different pharmaceutical preparations is mandatory. In this study, the local corneal tolerance and safety profile of three common tacrolimus 0.03% pharmaceutical preparations were evaluated.Corneal irritation and permeability of tacrolimus preparations were evaluated with the bovine corneal opacity and permeability (BCOP) test. Complementary corneal hematoxylin/eosin and immunohistochemistry staining for tight junctions and adherent juncti…

0301 basic medicinemedicine.medical_specialtyPathologygenetic structuresH&E stainCorneal irritationmedicine.disease_causePermeabilityTacrolimusCorneal permeabilityCornea03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineCorneal OpacityOphthalmologymedicineAnimalsDose-Response Relationship Drugbusiness.industryCorneal opacityImmunohistochemistryeye diseasesSensory SystemsTacrolimusOphthalmologySafety profileDisease Models Animal030104 developmental biologyPermeability (electromagnetism)030221 ophthalmology & optometryIrritantsCattlesense organsIrritationOphthalmic SolutionsbusinessImmunosuppressive AgentsCurrent eye research
researchProduct

Myopia, the challenge of Ophthalmology and its worldwide “explosive epidemic”

2018

AdultAtropinePediatricsmedicine.medical_specialtyAdolescentExplosive materialContact LensesMEDLINE02 engineering and technology01 natural sciences010309 optics020210 optoelectronics & photonicsRisk Factors0103 physical sciencesMyopia0202 electrical engineering electronic engineering information engineeringmedicineHumansAge of OnsetChildLife StyleLightingLife stylebusiness.industryIncidenceIncidence (epidemiology)Disease progressionGeneral MedicineEyeglassesOphthalmic solutionsDisease ProgressionSunlightMorbidityOphthalmic SolutionsAge of onsetbusinessArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Gentamicin, norfloxacin and lysozyme concentration in human tears: in vivo and in vitro study

1992

Hen's egg lysozyme (HEL) activity was measured in vitro with gentamicin and norfloxacin by a turbidimetric technique. Gentamicin at the concentration of 10(-3) M inhibited HEL activity by 39%, while 10(-3) M norfloxacin did not affect HEL activity. However, an in vivo study in healthy persons did not show any significant statistical difference in tear lysozyme activity when 0.3% gentamicin or 0.3% norfloxacin were topically applied.

AdultMaleAdolescentEgg lysozymechemical and pharmacologic phenomenaIn Vitro TechniquesgentamicinPharmacologyMicrobiologyCorneachemistry.chemical_compoundIn vivomedicineHumansIn vitro studyheterocyclic compounds[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrganslysozymeNorfloxacinocular surface[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyChemistryhemic and immune systemsGeneral Medicinebiochemical phenomena metabolism and nutritioninfectionIn vitroOphthalmology[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansTearsTearsMuramidaseGentamicinGentamicinsOphthalmic SolutionsLysozyme[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyNorfloxacinmedicine.drugActa Ophthalmologica
researchProduct

Corneal thickness differences between sexes after oxybuprocaine eye drops.

2014

PURPOSE We aimed to analyze the corneal thickness (CT) values of female and male subjects before and after instillation of oxybuprocaine 0.4% anesthetic eye drops. METHODS The CT of 30 female subjects and 28 male subjects was measured using scanning-slit corneal topography (Orbscan Topography System II, Orbscan, Inc, Salt Lake City, UT). Measurements were carried out before and 3 minutes after the instillation of oxybuprocaine 0.4% eye drops. RESULTS The difference between the baseline values and those obtained after anesthesia ranged as follows: male subjects: central, -26 to +24 μm; superior, -24 to +23 μm; inferior, -19 to +20 μm; nasal, -25 to +30 μm; and temporal, -21 to +20 μm; female…

AdultMalemedicine.medical_specialtyAdolescentSalt lakeCorneaYoung AdultSex FactorsOphthalmologymedicineHumansProspective StudiesOxybuprocaineAnesthetics LocalBaseline valuesmedicine.diagnostic_testbusiness.industryCorneal TopographyOrgan SizeCorneal topographyOphthalmologyAnestheticFemaleOphthalmic SolutionsbusinessProcaineOptometrymedicine.drugOptometry and vision science : official publication of the American Academy of Optometry
researchProduct

Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis

2020

Purpose Voriconazole was shown to inhibit ergosterol synthesis in various acanthamoeba species. The purpose of this study was to evaluate the clinical outcome of treatment with supplemental topical voriconazole in patients with acanthamoeba keratitis (AK). Methods All patients who had been treated for AK with voriconazole 1% drops in conjunction with topical first-line antiacanthamoeba therapy composed of polyhexamethylene biguanide (PHMB) 0.02% and propamidine isethionate 0.1% (Brolene) between November 2014 and August 2017 at the Department of Ophthalmology, University Medical Center Mainz, were included. The main outcomes were treatment failure and recurrence rate. Secondary outcomes wer…

AdultMalemedicine.medical_specialtyAntifungal AgentsVisual acuitymedicine.drug_classAntiprotozoal AgentsVisual AcuityAcanthamoebaCorneaYoung Adult03 medical and health sciences0302 clinical medicinePharmacotherapymedicineAnimalsHumansIn patientEye Infections ParasiticAgedRetrospective StudiesAged 80 and overVoriconazoleDose-Response Relationship Drugbusiness.industryBiguanideRetrospective cohort studyMiddle AgedEye infectionmedicine.diseaseDermatologyBenzamidinesOphthalmologyAcanthamoeba KeratitisAcanthamoeba keratitis030221 ophthalmology & optometryDrug Therapy CombinationFemaleVoriconazoleOphthalmic Solutionsmedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up Studiesmedicine.drugCornea
researchProduct

Corneal Thickness Response after Anesthetic Eye Drops: Our Own Results and Meta-Analysis.

2017

We aimed to test if there are different patterns in the central corneal thickness (CCT) response after instilling oxybuprocaine anesthetic eye drops and also to determine whether there is a significant change in the CCT. CCT was measured in 60 eyes of 60 healthy subjects before and during the hour after oxybuprocaine 0.4% eye drops were instilled. In addition, a systematic review and meta-analysis were carried out in order to answer the following PICO (patient, intervention, comparison, and outcome) question: What effect do anesthetic eye drops have on CCT values? We found no significant changes in the mean CCT values during the hour’s observation (ANOVA, p=0.209), and the meta-analysis rev…

AdultMalemedicine.medical_specialtyArticle Subjectgenetic structureslcsh:MedicineGeneral Biochemistry Genetics and Molecular BiologyCornea03 medical and health sciences0302 clinical medicineOphthalmologyMedicineHumans030212 general & internal medicineProspective StudiesOxybuprocaineAnesthetics LocalGeneral Immunology and Microbiologybusiness.industrylcsh:RHealthy subjectsGeneral Medicineeye diseasesHealthy VolunteersMeta-analysisAnesthetic030221 ophthalmology & optometryFemaleAnalysis of variancesense organsOphthalmic SolutionsbusinessProcainemedicine.drugResearch ArticleBioMed research international
researchProduct

Ocular Penetration of Topically Applied Norfloxacin 0.3% in the Rabbits and in Humans

1992

The kinetics of topically applied norfloxacin 0.3 percent were studied in rabbit and man. All measurements were performed by high-pressure liquid chromatography. Norfloxacin concentrations were investigated five to 120 minutes in rabbit ocular tissues after instillation of a single drop. In normal eyes, after 30 minutes, mean +/- SEM levels were 14.3 +/- 3.7 micrograms/g in cornea, 3.3 +/- 0.7 micrograms/g in conjunctiva, 0.2 +/- 0.1 microgram/g in aqueous humor. After removal of the corneal epithelium concentrations were as follows: 84.2 +/- 15.8 micrograms/g, 7.3 +/- 2.3 micrograms/g, 8.6 +/- 1.9 micrograms/g respectively. Penetration in posterior ocular tissues were rather poor. In human…

AdultMalemedicine.medical_specialtyConjunctivaAdolescentgenetic structures[SDV]Life Sciences [q-bio]EyeCorneaPharmacokineticsCorneaOphthalmologymedicineAnimalsHumansTissue DistributionPharmacology (medical)Chromatography High Pressure LiquidNorfloxacinAgedAntibacterial agentCorneal epitheliumAged 80 and overPharmacologyLagomorphabiologybusiness.industryPenetration (firestop)Middle Agedbiology.organism_classificationeye diseasesSurgeryOphthalmologymedicine.anatomical_structureFemaleRabbitssense organsOphthalmic SolutionsbusinessKeratoplasty PenetratingNorfloxacinmedicine.drugJournal of Ocular Pharmacology and Therapeutics
researchProduct